Collectively, these data indicate CREBBP/EP300 is a highly associated pathway in localized human fibrosis that controls key aspects of myofibroblast phenotype and function, including ACTA2 and COL1A1 gene expression and cell contractility. This evidence concerns the gene COL1A1 and fibrosis.